TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Business News

    Squawk on the Street

    CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer, David Faber and Sara Eisen is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds.

    Advertise

    Copyright: © 2024 CNBC

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    COVID-19 Worries Pressure Stocks, Presidential Transition: The Business Community Speaks Out, Exclusive With Media Mogul John Malone, And GoodRx Co-CEO Reacts To Amazon Pharmacy Nov 19, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discussed the Dow and S&P 500 extending Wednesday's losses on worries about COVID-19, with deaths surpassing 250,000 in the U.S. -- and the

    recent surge in cases resulting in lockdowns. The anchors also took a closer look at a push by business leaders and industry groups urging the White House to work with President-Elect Biden's transition team despite President Trump challenging the election results. David spoke exclusively with legendary media mogul and Liberty Media Chairman John Malone, who offered his take on everything from stimulus and the economic recovery to streaming and the direct-to-consumer landscape. GoodRx Co-CEO Doug Hirsch appeared on the program. The company's shares have tumbled since Amazon announced the launch of its own online pharmacy.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    FAA To Boeing: 737 MAX Can Return To The Skies, Dow 30,000 Watch, Retail Earnings Parade, And A Chevron CEO Exclusive Nov 18, 2020
    Show notes

    With the Dow looking to reach the 30,000 mark, Carl Quintanilla, Jim Cramer and David Faber discussed big news involving Boeing: The FAA approved the return of the company's long-grounded 737 MAX jet to service. They explored what this decision means for Boeing as well the airlines that have been struggling due to the pandemic. Also in focus: Retail earnings from the likes of Target and Lowe's ahead of the holiday season -- plus how the markets might be affected if President Trump refuses to leave the White House. Also hear who JPMorgan Chase CEO Jamie Dimon accused of exhibiting "childish behavior.” In an exclusive interview, Chevron Chairman & CEO Michael Wirth spoke about his company's growth strategy and engaged in a spirited discussion with Jim and David about drilling in the Arctic National Wildlife Refuge.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Amazon’s Drug Store, The COVID Consumer, And Musk’s Billions Nov 17, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discuss Amazon’s latest move into the pharmacy space, offering online prescription fulfillment & free delivery for Prime members. The launch of Amazon Pharmacy pressuring shares of traditional drug store retailers like Walgreens (WBA) & CVS Health (CVS) Rite Aid (RAD), as well as pharmacy start-ups like GoodRX (GDRX). Plus, watching retail and the COVID consumer, key reports from Walmart, Home Depot & Kohl’s, stocks pull back a day after setting new records. And Elon Musk’s billions, on track to become the world’s 3rd richest person as Tesla gains a spot in the S&P 500. Tesla among the highest-valued companies ever the enter the benchmark index.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Moderna COVID-19 Vaccine News Sparks Market Rally, Dow 30,000 Watch, And In M&A: A $11.6B Banking Deal Nov 16, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discussed a big start to the week for the markets: The Dow and S&P 500 rally after drug maker Moderna announced that preliminary analysis of a phase 3 trial showed its experimental COVID-19 vaccine had an efficacy rate of 94.5-percent and saw no significant safety concerns. The Moderna news putting the Dow closer to hitting the 30,000 mark for the first time ever while giving a boost to travel, leisure and restaurant stocks -- but putting pressure on "stay-at-home" stocks such as Zoom Media and Peloton. The anchors also took a closer look at today's M&A developments, including PNC agreeing to buy the U.S. unit of Spain's BBVA for $11.6 billion in cash. The deal is the second-biggest U.S. banking transaction since the 2008 financial crisis, trailing only last year’s acquisition of SunTrust Banks by BB&T for $28.2 billion, which resulted in the creation of Truist Financial.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Stocks Rebound, Disney Jumps On Q4 Results, Cisco CEO On Earnings Beat, And Doordash Files For An IPO Nov 13, 2020
    Show notes

    Carl Quintanilla and Jim Cramer discussed how stocks are rebounding after Thursday’s sell-off. The anchors spoke about market reaction to NBC News and other news outlets calling Arizona for President-Elect Joe Biden. They also highlighted the importance of drug makers providing guidance as to when COVID-19 vaccines and treatments might become available to the public. One of the top stories: Disney’s better-than-expected quarterly results. Carl and Jim reacted to what Disney CEO Bob Chapek said on his company’s earnings call about Disney+ subscriber growth -- and California refusing to allow the re-opening of Disneyland in wake of the pandemic. Cisco CEO Chuck Robbins appeared on the program to discuss his company’s stronger-than-expected earnings and how it is benefiting from work-at-home trends.

    Also in focus: Delivery service Doordash filing for an IPO.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Surge in COVID-19 Cases Impacts The Markets, Airline Shares Under Pressure, Stay-At-Home Stocks Rebound Nov 12, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discussed the big spike in COVID-19 cases putting pressure on the Dow and S&P 500. The anchors explored everything from how soon vaccines might

    become available to complacency among the public and where lockdowns could come into play. Also in focus: Airline stocks under pressure after Southwest said it recently experienced

    a deceleration in improving revenue trends. "Stay-at-home" stocks including Zoom Media were among the bright spots, rebounding after positive vaccine news sent them tumbling earlier in the week.

    The Co-Founder and Co-CEO of online prescription drug platform "GoodRx" appeared on the program to discuss the company's first quarterly report since going public in September.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Can The Rally Continue?, The COVID-19 And Vaccine Effect On Stocks, And A Tough Day For Alibaba And Chinese Stocks Nov 11, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks and whether they can maintain their upward momentum. The anchors reacted to a new note from

    Goldman Sachs Chief U.S. Equity Strategist David Kostin, who is raising his year-end S&P 500 price target to 3,700. They also explored buying strategies when it comes to value versus growth and where

    COVID-19 and vaccines come into play. Also in focus: President Trump’s refusal to concede the 2020 election and what that means for the markets, Alibaba shares falling after Chinese regulators drafted anti-monopoly guidelines, and what’s driving a strong session for chip stocks.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Morning After The Mega-Rally, Lilly's COVID-19 Antibody Treatment Gets FDA Emergency Approval, And An Exclusive With McDonald's CEO Nov 10, 2020
    Show notes

    Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for stocks one day after the Dow, S&P 500 and Nasdaq each surged to record intraday highs. They explored the concept of buying value and selling growth -- and which stocks

    went from "cheap to overvalued" during Monday's rally. The anchors also reacted to what Eli Lilly CEO David Ricks told CNBC after the FDA authorized the company's COVID-19 antibody treatment for emergency use.

    In a CNBC Exclusive, McDonald's CEO Chris Kempczinski told Carl what Monday's news about Pfizer's COVID-19 vaccine candidate could mean for the fast-food giant. He also discussed the company's forthcoming plant-based burger called the "McPlant" and why he believes such products are here to stay.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Stocks Make History: All-Time Highs For Dow, S&P 500 Nov 09, 2020
    Show notes

    On the first trading day since Joe Biden was declared President-Elect, Carl Quintanilla, Jim Cramer and David Faber discussed a record-setting day for stocks. The Dow and S&P 500 each soaring to all-time intraday highs in reaction to Pfizer and BioNTech announcing that their COVID-19 vaccine candidate was found to be more than 90-percent effective in participants who were not previously infected. That news fueling hopes of a faster economic recovery and surges in airline, cruise line, bank and credit card stocks -- as well as shares of companies that operate theme parks including Disney. On the flip side, Biogen was the worst performer on the S&P 500, losing almost a third of its value after its Alzheimer's drug failed to win support from an FDA panel. Also, so-called "stay-at-home" stocks such as Zoom Media took a hit in reaction to the Pfizer vaccine news.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Squawk On The Street 11/06/20 Nov 06, 2020
    Show notes

    The opening hour of CNBC’s "Squawk on the Street" with Carl Quintanilla, Jim Cramer and David Faber is broadcast each weekday from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential CEOs and greatest market minds.


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


    Previous 1 269 270 271 272 273 304 Next

    Related Podcasts

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters

    1

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters Business
    WSJ Your Money Briefing

    2

    WSJ Your Money Briefing Business
    FORTUNE Unfiltered with Aaron Task

    3

    FORTUNE Unfiltered with Aaron Task Business
    FORTUNE OnStage Presents: The Most Powerful Women

    4

    FORTUNE OnStage Presents: The Most Powerful Women Business
    Slate Money

    5

    Slate Money Business
    In The Dark – The New Yorker

    6

    In The Dark – The New Yorker Business News
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights